Salzhauer Michael’s Cue Biopharma CUE Stock Holding History

Salzhauer Michael’s Portfolio CUE Stock Details CUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-533	Closed	-$10.9K	–	94
2025 Q2	$10.9K	Buy	+533	New	+$11.4K	0.01%	80

Other funds holding CUE

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

GWMR

GC Wealth Management RIA Cambridge, Massachusetts $1.73B AUM 16.14% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

RSWM

Robertson Stephens Wealth Management San Francisco, California $4.06B AUM 32.22% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Salzhauer Michael's CUE Position: Q3 2025 in Review

Salzhauer Michael sold out of Cue Biopharma (CUE) in Q3 2025, closing a stake of 533 shares — an estimated $10.9K sold.

Salzhauer Michael first reported a position in CUE in Q2 2025 and held it in 1 quarter. The position peaked at $10.9K in Q2 2025. 51 funds tracked by Wall St. Rank hold CUE as of Q3 2025.

Salzhauer Michael reported no remaining Cue Biopharma position as of Q3 2025 after selling out during the quarter.
Salzhauer Michael sold 533 Cue Biopharma shares in Q3 2025, an estimated $10.9K.
Salzhauer Michael first reported a position in Cue Biopharma in Q2 2025 and held it in 1 quarter.
Salzhauer Michael's Cue Biopharma position peaked at $10.9K in Q2 2025.
51 funds tracked by Wall St. Rank held Cue Biopharma as of Q3 2025.

Based on Salzhauer Michael's 13F filing for Q3 2025, filed 20 Oct 2025.